{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T22:03:35Z","timestamp":1766441015178},"reference-count":136,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invasive candidiasis (IC) has become a serious problem in the intensive care unit patients with an attributable mortality rate that can reach up to 51%. Multiple global surveillance studies have shown an increasing incidence of candidemia. Despite their limited sensitivity (21\u201371%), cultures remain the gold standard for the diagnosis of IC associated with candidemia. Many adjunct laboratory tests exist to support or rule out the diagnosis, each with its indications and limitations, including procalcitonin, 1,3-\u03b2-D-glucan, mannan and anti-mannan antibodies, and Candida albicans germ tube antibody. In addition, polymerase chain reaction-based methods could expedite species identification in positive blood cultures, helping in guiding early empirical antifungal therapy. The management of IC in critically ill patients can be classified into prophylactic, preemptive, empiric, and directed\/targeted therapy of a documented infection. There is no consensus concerning the benefit of prophylactic therapy in critically ill patients. While early initiation of appropriate therapy in confirmed IC is an important determinant of survival, the selection of candidates and drug of choice for empirical systemic antifungal therapy is more controversial. The choice of antifungal agents is determined by many factors, including the host, the site of infection, the species of the isolated Candida, and its susceptibility profile. Echinocandins are considered initial first-line therapy agents. Due to the conflicting results of the various studies on the benefit of preemptive therapy for critically ill patients and the lack of robust evidence, the Infectious Diseases Society of America (IDSA) omitted this category from its updated guidelines and the European Society of Intensive Care Medicine (ESICM) and the Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) do not recommend it.<\/jats:p>","DOI":"10.1055\/s-0041-1741009","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T23:32:33Z","timestamp":1645054353000},"page":"046-059","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients"],"prefix":"10.1055","volume":"43","author":[{"given":"Aline El","family":"Zakhem","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachid","family":"Istambouli","sequence":"additional","affiliation":[{"name":"Leeds and York Partnership NHS Foundation Trust, Leeds, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Francois","family":"Jabbour","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Saint George Hospital University Medical Center, University of Balamand, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joya-Rita","family":"Hindy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Gharamti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, Waterbury Hospital, Waterbury, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souha S.","family":"Kanj","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"07","key":"ref1","doi-asserted-by":"crossref","first-page":"e036452","DOI":"10.1136\/bmjopen-2019-036452","article-title":"Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis","volume":"10","author":"Z Zhang","year":"2020","journal-title":"BMJ Open"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"M A Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2016.06.029","article-title":"Candidemia and invasive candidiasis in adults: a narrative review","volume":"34","author":"S Antinori","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"09","key":"ref4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)","volume":"40","author":"O Lortholary","year":"2014","journal-title":"Intensive Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vhri.2019.07.002","article-title":"The economic burden of candidemia and invasive candidiasis: a systematic review","volume":"21","author":"W NA Wan Ismail","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13613-020-00755-8","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis","volume":"10","author":"M Schroeder","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","article-title":"Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period","volume":"40","author":"A L Colombo","year":"2014","journal-title":"Intensive Care Med"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13054-020-2766-1","article-title":"Risk factors for candidemia: a prospective matched case-control study","volume":"24","author":"J Poissy","year":"2020","journal-title":"Crit Care"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","article-title":"Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006)","volume":"37","author":"O Leroy","year":"2009","journal-title":"Crit Care Med"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000","volume":"38","author":"O Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-13-10","article-title":"A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study","volume":"13","author":"S-P Yang","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/JCM.00409-07","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing","volume":"45","author":"M A Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jiph.2019.05.007","article-title":"Epidemiology and burden of invasive fungal infections in the countries of the Arab League","volume":"13","author":"J Kmeid","year":"2020","journal-title":"J Infect Public Health"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/pathogens10010082","article-title":"Predominance of candida glabrata among non-albicans Candida species in a 16-year study of candidemia at a tertiary care center in Lebanon","volume":"10","author":"A E Zakhem","year":"2021","journal-title":"Pathogens"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004-2008","volume":"74","author":"M Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s15010-013-0432-0","article-title":"Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)","volume":"41","author":"M T Montagna","year":"2013","journal-title":"Infection"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.riam.2019.06.003","article-title":"Candidemia in a public hospital in Northeastern Brazil: epidemiological features and risk factors in critically ill patients","volume":"36","author":"R B da Silva","year":"2019","journal-title":"Rev Iberoam Micol"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"87.e1","DOI":"10.1016\/j.cmi.2014.08.011","article-title":"Invasive candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008)","volume":"21","author":"L Klingspor","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"e0127534","DOI":"10.1371\/journal.pone.0127534","article-title":"Clinical and therapeutic aspects of candidemia: a five year single centre study","volume":"10","author":"M Bassetti","year":"2015","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","article-title":"Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris","volume":"6","author":"A Cortegiani","year":"2018","journal-title":"J Intensive Care"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S1473-3099(18)30609-1","article-title":"Candida auris: a global fungal public health threat","volume":"18","author":"J F Meis","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/jof7060440","article-title":"Impact of the SARS-CoV-2 pandemic in candidaemia, invasive Aspergillosis and antifungal consumption in a tertiary hospital","volume":"7","author":"J V Mulet Bayona","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/pathogens10020157","article-title":"First Candida auris outbreak during a COVID-19 pandemic in a tertiary-care center in Lebanon","volume":"10","author":"F Allaw","year":"2021","journal-title":"Pathogens"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.idc.2015.10.013","article-title":"Invasive candidiasis","volume":"30","author":"T P McCarty","year":"2016","journal-title":"Infect Dis Clin North Am"},{"issue":"09","key":"ref25","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \"missing 50%\" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"C J Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2334-10-150","article-title":"Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study","volume":"10","author":"M D Zilberberg","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to candida infection: importance of empiric therapy and source control","volume":"54","author":"M Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/myc.12869","article-title":"Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections definitions in ICU patients (FUNDICU) project","volume":"62","author":"M Bassetti","year":"2019","journal-title":"Mycoses"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"J P Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"S 02","key":"ref30","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"M Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dks347","article-title":"Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections","volume":"68","author":"J Garnacho-Montero","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"09","key":"ref32","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.clinthera.2014.06.028","article-title":"Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study","volume":"36","author":"S T Micek","year":"2014","journal-title":"Clin Ther"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00134-014-3355-z","article-title":"Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later","volume":"40","author":"P Eggimann","year":"2014","journal-title":"Intensive Care Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ijantimicag.2013.04.008","article-title":"Management of candidaemia and invasive candidiasis in critically ill patients","volume":"42","author":"J Chahoud","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"ref35","first-page":"524","volume-title":"Diagnosis and Treatment of Candidemia in the Intensive Care Unit","author":"M Bassetti","year":"2019"},{"issue":"08","key":"ref36","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1128\/JCM.00609-11","article-title":"Quantitation of Candida CFU in initial positive blood cultures","volume":"49","author":"C D Pfeiffer","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"P G Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"C Le\u00f3n","year":"2006","journal-title":"Crit Care Med"},{"issue":"03","key":"ref39","first-page":"139","article-title":"Risk factors for candidemia in non-neutropenic critical patients in Colombia","volume":"40","author":"G Ort\u00edz Ruiz","year":"2016","journal-title":"Med Intensiva"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.ajic.2017.02.022","article-title":"Risk factors, characteristics, and outcomes of candidemia in an adult intensive care unit in Turkey","volume":"45","author":"E Tukenmez Tigen","year":"2017","journal-title":"Am J Infect Control"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/myc.12872","article-title":"Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: a matched cohort study","volume":"62","author":"E Dudoignon","year":"2019","journal-title":"Mycoses"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.burns.2019.01.005","article-title":"Candidemia in major burn patients and its possible risk factors: a 6-year period retrospective study at a burn ICU","volume":"45","author":"J Zhou","year":"2019","journal-title":"Burns"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"e0153247","DOI":"10.1371\/journal.pone.0153247","article-title":"Intra-abdominal candidiasis: the importance of early source control and antifungal treatment","volume":"11","author":"P Vergidis","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/archsurg.137.12.1341","article-title":"Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients","volume":"137","author":"H Dupont","year":"2002","journal-title":"Arch Surg"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cld.491","article-title":"Hepatosplenic candidiasis","volume":"6","author":"O A Cornely","year":"2015","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10096-008-0466-x","article-title":"Candida infective endocarditis","volume":"27","author":"J W Baddley","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref47","first-page":"439","volume-title":"Systemic candidiasis","author":"B Pilmis","year":"2017"},{"issue":"06","key":"ref48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11046-020-00492-3","article-title":"Candida endocarditis in patients with candidemia: a single-center experience of 14 cases","volume":"185","author":"F Hitzenbichler","year":"2020","journal-title":"Mycopathologia"},{"issue":"01","key":"ref49","first-page":"e6695","article-title":"Candida endocarditis: a review of the pathogenesis, morphology, risk factors, and management of an emerging and serious condition","volume":"12","author":"S Mamtani","year":"2020","journal-title":"Cureus"},{"issue":"05","key":"ref50","doi-asserted-by":"crossref","first-page":"e01909-17","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","volume":"56","author":"C J Clancy","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1128\/JCM.02048-13","article-title":"Evaluation of bactec mycosis IC\/F and plus aerobic\/F blood culture bottles for detection of Candida in the presence of antifungal agents","volume":"51","author":"R K\u00f6ck","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5858\/133.1.93","article-title":"Optimal use of Myco\/F lytic and standard BACTEC blood culture bottles for detection of yeast and mycobacteria","volume":"133","author":"J E Kirby","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/JCM.01014-08","article-title":"Detection of bacterial and yeast species with the Bactec 9120 automated system with routine use of aerobic, anaerobic, and fungal media","volume":"46","author":"A Chiarini","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/159.3.495","article-title":"Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients","volume":"159","author":"M J Ness","year":"1989","journal-title":"J Infect Dis"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.3390\/jof6030101","article-title":"Molecular methods for the diagnosis of invasive candidiasis","volume":"6","author":"I Camp","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/jof7020127","article-title":"The evolving landscape of fungal diagnostics, current and emerging microbiological approaches","volume":"7","author":"Z Freeman Weiss","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"06","key":"ref57","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1186\/cc9365","article-title":"The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the third European Conference on Infections in Leukemia","volume":"14","author":"M Mikulska","year":"2010","journal-title":"Crit Care"},{"issue":"01","key":"ref58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13054-016-1324-3","article-title":"Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions","volume":"20","author":"C Le\u00f3n","year":"2016","journal-title":"Crit Care"},{"issue":"08","key":"ref59","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00134-015-3922-y","article-title":"\u03b2-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis","volume":"41","author":"E Mart\u00edn-Mazuelos","year":"2015","journal-title":"Intensive Care Med"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jmii.2019.02.001","article-title":"Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients","volume":"53","author":"L Trovato","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"ref61","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/myc.13170","article-title":"Quantification of 1,3-\u03b2-d-glucan by Wako \u03b2-glucan assay for rapid exclusion of invasive fungal infections in critical patients: a diagnostic test accuracy study","volume":"63","author":"V Cento","year":"2020","journal-title":"Mycoses"},{"issue":"07","key":"ref62","doi-asserted-by":"crossref","first-page":"e0236095","DOI":"10.1371\/journal.pone.0236095","article-title":"Comparative performance evaluation of Wako \u03b2-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases","volume":"15","author":"E De Carolis","year":"2020","journal-title":"PLoS One"},{"issue":"04","key":"ref63","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","article-title":"A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-\u03b2-D-glucan for invasive fungal infection: focus on cutoff levels","volume":"48","author":"S He","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","article-title":"ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients","volume":"45","author":"I Martin-Loeches","year":"2019","journal-title":"Intensive Care Med"},{"issue":"05","key":"ref65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/ijccm.IJCCM_4_18","article-title":"Experience with \u03b2-D-glucan assay in the management of critically ill patients with high risk of invasive candidiasis: an observational study","volume":"22","author":"N Bansal","year":"2018","journal-title":"Indian J Crit Care Med"},{"issue":"09","key":"ref66","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkw188","article-title":"Discontinuation of empirical antifungal therapy in ICU patients using 1,3-\u03b2-d-glucan","volume":"71","author":"M Nucci","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"ref67","first-page":"3488","article-title":"Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital","volume":"73","author":"R Rautemaa-Richardson","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref68","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00134-017-4932-8","article-title":"Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial","volume":"43","author":"A Rouz\u00e9","year":"2017","journal-title":"Intensive Care Med"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13054-020-03265-y","article-title":"(1,3)-\u03b2-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial","volume":"24","author":"G De Pascale","year":"2020","journal-title":"Crit Care"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13054-020-03450-z","article-title":"Letter on \u201c(1,3)-\u03b2-D-glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial\u201d","volume":"25","author":"A Kritikos","year":"2021","journal-title":"Crit Care"},{"issue":"12","key":"ref71","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.23736\/S0375-9393.18.12619-8","article-title":"Determination of 1,3-\u03b2-D-glucan in the peritoneal fluid for the diagnosis of intra-abdominal candidiasis in critically ill patients: a pilot study","volume":"84","author":"E Novy","year":"2018","journal-title":"Minerva Anestesiol"},{"issue":"07","key":"ref72","doi-asserted-by":"crossref","first-page":"e1415","DOI":"10.1093\/cid\/ciaa1370","article-title":"The Presence of (1\u21923)-\u03b2-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery","volume":"73","author":"P L White","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref73","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1093\/jac\/dkv241","article-title":"Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment","volume":"70","author":"M C Mart\u00ednez-Jim\u00e9nez","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"09","key":"ref74","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/cid\/cis200","article-title":"Performance of Candida real-time polymerase chain reaction, \u03b2-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis","volume":"54","author":"M H Nguyen","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref75","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cid\/ciu292","article-title":"Emerging technologies for rapid identification of bloodstream pathogens","volume":"59","author":"A Kothari","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref76","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QCO.0000000000000594","article-title":"Rapid diagnosis of invasive candidiasis: ready for prime-time?","volume":"32","author":"C J Clancy","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"09","key":"ref77","doi-asserted-by":"crossref","first-page":"e00591","DOI":"10.1128\/JCM.00591-18","article-title":"Rapid detection of Candida auris based on loop-mediated isothermal amplification (LAMP)","volume":"56","author":"M Yamamoto","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"06","key":"ref78","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1060028014529928","article-title":"Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics","volume":"48","author":"S L Aitken","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"03","key":"ref79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/jof5030086","article-title":"Diagnostic performance of a novel multiplex PCR assay for candidemia among ICU patients","volume":"5","author":"S Fuchs","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/femsre\/fuz015","article-title":"Recent trends in molecular diagnostics of yeast infections: from PCR to NGS","volume":"43","author":"T Gabald\u00f3n","year":"2019","journal-title":"FEMS Microbiol Rev"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fcimb.2019.00019","article-title":"Investigating antifungal susceptibility in Candida species with MALDI-TOF MS-based assays","volume":"9","author":"M Delavy","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12879-019-4419-z","article-title":"Pooled analysis of T2 Candida for rapid diagnosis of candidiasis","volume":"19","author":"D L Tang","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"04","key":"ref83","doi-asserted-by":"crossref","first-page":"e01756","DOI":"10.1128\/JCM.01756-17","article-title":"Efficacy of T2 magnetic resonance assay in monitoring candidemia after initiation of antifungal therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) trial","volume":"56","author":"E Mylonakis","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref84","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-017-1763-5","article-title":"Combined use of serum (1,3)-\u03b2-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units","volume":"21","author":"D R Giacobbe","year":"2017","journal-title":"Crit Care"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13054-019-2481-y","article-title":"Procalcitonin levels in candidemia versus bacteremia: a systematic review","volume":"23","author":"A Cortegiani","year":"2019","journal-title":"Crit Care"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13054-019-2720-2","article-title":"Biomarkers to delineate bacteremia from candidemia remain a challenging issue","volume":"24","author":"P M Honore","year":"2020","journal-title":"Crit Care"},{"issue":"05","key":"ref87","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"C Le\u00f3n","year":"2009","journal-title":"Crit Care Med"},{"issue":"01","key":"ref88","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/2110-5820-1-50","article-title":"Evaluation of \u201cCandida score\u201d in critically ill patients: a prospective, multicenter, observational, cohort study","volume":"1","author":"G Leroy","year":"2011","journal-title":"Ann Intensive Care"},{"issue":"02","key":"ref89","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/cc12569","article-title":"Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis","volume":"17","author":"A M Hall","year":"2013","journal-title":"Crit Care"},{"issue":"08","key":"ref90","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4103\/ijccm.IJCCM_33_17","article-title":"External validation of risk prediction scores for invasive candidiasis in a medical\/surgical intensive care unit: an observational study","volume":"21","author":"A Ahmed","year":"2017","journal-title":"Indian J Crit Care Med"},{"issue":"06","key":"ref91","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"D Pittet","year":"1994","journal-title":"Ann Surg"},{"issue":"01","key":"ref92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1439-0507.2009.01756.x","article-title":"Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit","volume":"54","author":"L Ostrosky-Zeichner","year":"2011","journal-title":"Mycoses"},{"issue":"12","key":"ref93","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00134-009-1619-9","article-title":"Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients","volume":"35","author":"E G Playford","year":"2009","journal-title":"Intensive Care Med"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/bja\/aew117","article-title":"Compliance with an empirical antimicrobial protocol improves the outcome of complicated intra-abdominal infections: a prospective observational study","volume":"117","author":"M Guilbart","year":"2016","journal-title":"Br J Anaesth"},{"issue":"01","key":"ref95","first-page":"CD004920","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients","author":"E G Playford","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref96","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/01.CCM.0000208357.05675.C3","article-title":"Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials","volume":"34","author":"K Z Vardakas","year":"2006","journal-title":"Crit Care Med"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0031-1275528","article-title":"Candida prophylaxis and therapy in the ICU","volume":"32","author":"P M Echeverria","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"issue":"05","key":"ref98","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00134-009-1405-8","article-title":"Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients","volume":"35","author":"L Senn","year":"2009","journal-title":"Intensive Care Med"},{"issue":"09","key":"ref99","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"L Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref100","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts","volume":"39","author":"M Bassetti","year":"2013","journal-title":"Intensive Care Med"},{"issue":"04","key":"ref101","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"P G Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"08","key":"ref102","doi-asserted-by":"crossref","first-page":"e42282","DOI":"10.1371\/journal.pone.0042282","article-title":"\u03b2-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study","volume":"7","author":"K E Hanson","year":"2012","journal-title":"PLoS One"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10096-016-2796-4","article-title":"Potential clinical and economic outcomes of active beta-D-glucan surveillance with preemptive therapy for invasive candidiasis at intensive care units: a decision model analysis","volume":"36","author":"Y K Pang","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"ref104","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/myc.12221","article-title":"Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery","volume":"57","author":"J Prattes","year":"2014","journal-title":"Mycoses"},{"issue":"07","key":"ref105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1345\/aph.1K010","article-title":"Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese guidelines","volume":"41","author":"R Tsuruta","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"02","key":"ref106","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1086\/375603","article-title":"Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy","volume":"37","author":"J J De Waele","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref107","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"R Piarroux","year":"2004","journal-title":"Crit Care Med"},{"issue":"09","key":"ref108","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"M Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"K W Garey","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jac\/dkr511","article-title":"Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes","volume":"67","author":"S A Grim","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"01","key":"ref111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","article-title":"Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study","volume":"6","author":"O Leroy","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"02","key":"ref112","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"M G Schuster","year":"2008","journal-title":"Ann Intern Med"},{"issue":"05","key":"ref113","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jinf.2010.08.013","article-title":"Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults","volume":"61","author":"J A Troughton","year":"2010","journal-title":"J Infect"},{"issue":"15","key":"ref114","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial","volume":"316","author":"J F Timsit","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"ref115","doi-asserted-by":"crossref","first-page":"E1672","DOI":"10.21037\/jtd.2016.12.97","article-title":"Antifungal use in intensive care units: another uncertainty that highlights the need for precision medicine","volume":"8","author":"R Moghnieh","year":"2016","journal-title":"J Thorac Dis"},{"issue":"S 06","key":"ref116","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"D S Perlin","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"07","key":"ref117","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.00285-15","article-title":"Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital","volume":"59","author":"B Posteraro","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"ref118","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"A C Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2334-11-261","article-title":"Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome","volume":"11","author":"A C Reboli","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"05","key":"ref120","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/cc10514","article-title":"Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis","volume":"15","author":"D H Kett","year":"2011","journal-title":"Crit Care"},{"issue":"01","key":"ref121","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/ijmm.IJMM_17_400","article-title":"Echinocandins: their role in the management of Candida biofilms","volume":"36","author":"S Swaminathan","year":"2018","journal-title":"Indian J Med Microbiol"},{"issue":"08","key":"ref122","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"D R Andes","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"05","key":"ref123","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijantimicag.2016.02.004","article-title":"Pharmacokinetic\/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations","volume":"47","author":"Q Yang","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"ref124","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciu158","article-title":"Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis","volume":"58","author":"M Fern\u00e1ndez-Ruiz","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","article-title":"Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients","volume":"45","author":"R Bellmann","year":"2017","journal-title":"Infection"},{"issue":"12","key":"ref126","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"B D Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref127","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/AAC.04134-14","article-title":"Abdominal candidiasis is a hidden reservoir of echinocandin resistance","volume":"58","author":"R K Shields","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"03","key":"ref128","first-page":"CD000969","article-title":"Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia","author":"H K Johansen","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"S 04","key":"ref129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-0691.2008.01984.x","article-title":"Liposomal amphotericin B: what is its role in 2008?","volume":"14","author":"F Lanternier","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"04","key":"ref130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/jof6040380","article-title":"Candida lusitaniae breakthrough fungemia in an immuno-compromised adolescent: case report and review of the literature","volume":"6","author":"A Apsemidou","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"09","key":"ref131","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/antibiotics9090568","article-title":"Antifungal resistance in Candida auris: molecular determinants","volume":"9","author":"M G Fr\u00edas-De-Le\u00f3n","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"ref132","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/14787210.2018.1528872","article-title":"Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis","volume":"16","author":"S Keane","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"S 06","key":"ref133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1469-0691.12622","article-title":"Antifungal stewardship in invasive Candida infections","volume":"20","author":"M Ruhnke","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref134","first-page":"ciab562","article-title":"The landscape of candidemia during the COVID-19 pandemic","author":"E E Seagle","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref135","doi-asserted-by":"crossref","first-page":"e2018028","DOI":"10.4084\/mjhid.2018.028","article-title":"Appropriate duration of intravenous treatment of candidemia and timing of step down to oral therapy in non-neutropenic patients","volume":"10","author":"R W Dib","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"06","key":"ref136","doi-asserted-by":"crossref","first-page":"b250","DOI":"10.1093\/ofid\/ofab250","article-title":"Early stepdown from echinocandin to fluconazole treatment in candidemia: a post hoc analysis of three cohort studies","volume":"8","author":"E Moreno-Garc\u00eda","year":"2021","journal-title":"Open Forum Infect Dis"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1741009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T05:01:33Z","timestamp":1674795693000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1741009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":136,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2022,2,16]]},"published-print":{"date-parts":[[2022,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1741009","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}